risedronate s.k.
k.s.kim international (sk- pharma) ltd., israel - risedronic acid as sodium hemipentahydrate - tablets - risedronic acid as sodium hemipentahydrate 150 mg - risedronic acid - treatment of postmenopausal osteoporosis. prevention of postmenopausal osteoporosis.
actonel once a month 150 mg
truemed ltd, israel - risedronic acid as sodium - film coated tablets - risedronic acid as sodium 150 mg - risedronic acid - treatment of postmenopausal osteoporosis.prevention of postmenopausal osteoporosis.
ribone 35
unipharm ltd, israel - risedronic acid - tablets - risedronic acid 35 mg - risedronic acid - treatment of postmenopausal osteoporosis to reduce the risk of vertebral fractures. treatment of established postmenopausal osteoporosis to reduce the risk of hip fractures. prevention of osteoporosis in postmenopausal women with increased risk of osteoporosis. treatment of osteoporosis in men at high risk of fracture.
actonel® once -a-month film coated tablet 150mg
zuellig pharma pte. ltd. - risedronic acid 139.2mg equivalent to risedronate sodium - tablet, film coated - 150mg - risedronic acid 139.2mg equivalent to risedronate sodium 150mg
palibone tablets film-coated
pharmathen s.a. - risedronic acid (risedronate sodium) - tablets film-coated - 35mg
actonel
teva pharma (new zealand) limited - risedronate sodium hemipentahydrate 30mg equivalent to 27.8 mg risedronic acid; - film coated tablet - 30 mg - active: risedronate sodium hemipentahydrate 30mg equivalent to 27.8 mg risedronic acid excipient: chroma-tone white ddb-7536w crospovidone dri-klear lactose monohydrate magnesium stearate powdered cellulose
actonel
teva pharma (new zealand) limited - risedronate sodium hemipentahydrate 5mg equivalent to 4.64 mg risedronic acid; - film coated tablet - 5 mg - active: risedronate sodium hemipentahydrate 5mg equivalent to 4.64 mg risedronic acid excipient: chroma-tone white (ddb-7536w) crospovidone dri-klear iron oxide yellow lactose monohydrate magnesium stearate powdered cellulose
risedronate teva ® 75 mg
abic marketing ltd - risedronic acid sodium 75 mg - tablets - risedronic acid - treatment of osteoporosis in postmenopausal women at increased risk of fractures.prevention of osteoporosis in postmenopausal women who are at risk of developing osteoporosis and for whom the desired clinical outcome is to maintain bone mass and to reduce the risk of fracture.
actonate 32.5 mg (equivalent to 35 mg risedronate sodium) film-coated tablet
endure medical, inc.; distributor: endure medical, inc. - risedronic acid (as risedronate sodium) - film-coated tablet - 32.5 mg (equivalent to 35 mg risedronate sodium)
risebon
pharmaceutical works polfa in pabianice jsc - risedronic acid (risedronate sodium) - tablets film-coated - 35mg